CBEYOND | Clinical Research Studies Listing

Recruiting

18 years - 85 years

All

Phase 3

1 Location

Brief description of study

Phase 3, Randomized, Controlled, Open-label Study to Compare the Efficacy and Safety of Bemnifosbuvir-Ruzasvir Fixed-dose Combination (BEM/RZR FDC) Versus Sofosbuvir-Velpatasvir Fixed-dose Combination (SOF/VEL FDC) in Subjects with Chronic Hepatitis C Virus (HCV) Infection

Detailed description of study

Penn researchers are looking for people who may be interested in taking part in the C-BEYOND clinical research study. The purpose of this study is to compare the safety and effectiveness of an investigational drug (study drug) with a comparator drug. The comparator drug is a generic version of a drug approved in the United States and Canada to treat HCV, but this generic version being used in the study has only been authorized in the United States. You may be eligible to participate in this HCV infection study if you:
•    are 18–85 years of age,
•    have a chronic HCV infection, and
•    do not have a hepatitis B virus infection.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Medical Research
Age: 18 years - 85 years
Gender: All

Documented HCV, No prior use of direct-acting antiviral (DAA) treatment

Updated on 02 Apr 2026. Study ID: 25-1103

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

View email

Phone

View phone

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Please provide your preferred way of contact

Other language

By Submitting your information, you agree that your details may be shared with the selected study site and handled in accordance with this Website's Privacy Policy (see link in footer). You may be contacted by email, text message, or phone regarding this study and other research opportunities that may be of interested to you. You can unsubscribe from these communications at any time. Message and data rates may apply.

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center